Neurocrine Biosciences, Inc.
Methods for the administration of certain VMAT2 inhibitors

Last updated:

Abstract:

Provided are methods of administering a vesicular monoamine transport 2 (VMAT2) inhibitor chosen from valbenazine, or a pharmaceutically acceptable salt and/or isotopic variant thereof, to a patient in need thereof.

Status:
Grant
Type:

Utility

Filling date:

3 Aug 2020

Issue date:

8 Jun 2021